Create value beyond the molecule.
Pharma is going through a slew of recent challenges and opportunities. On one hand, healthcare reform means that 30 million more people have access to prescription drugs. On the other, expiring patents mean that major firms are at risk for losing valuable revenue. Consumers are demonstrating growing concerns about price, safety and quality, but the rising numbers of the elderly population means demand will be higher than ever. Jump partners with pharma companies to rethink their innovation groups, reinvent the drug approvement process, think about strategy from a portfolio instead of drug based level.
We’ve been working on…
- Executive Leadership Alignment
- Future Scenario Planning
- Innovation Strategy
- Patient Engagement Strategy
- Product Launch Strategy